GB1136039A - Improvements relating to immunosuppressive agents - Google Patents

Improvements relating to immunosuppressive agents

Info

Publication number: GB1136039A
Authority: GB; United Kingdom
Prior art keywords: improvements relating; immunosuppressive agents; ribonuclease; oct; immunosuppressive
Prior art date: 1966-10-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

GB45695/66A

Other languages

English (en)

Inventor

James Frederick Mowbray

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

NAT RES DEV

National Research Development Corp UK

Original Assignee

NAT RES DEV

National Research Development Corp UK

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1966-10-12

Filing date

1966-10-12

Publication date

1968-12-11

1966-10-12 Application filed by NAT RES DEV, National Research Development Corp UK filed Critical NAT RES DEV

1966-10-12 Priority to GB45695/66A priority Critical patent/GB1136039A/en

1967-10-11 Priority to FR1552939D priority patent/FR1552939A/fr

1967-10-11 Priority to FR124050A priority patent/FR7058M/fr

1967-10-11 Priority to NL6713800A priority patent/NL6713800A/xx

1967-10-11 Priority to ES345979A priority patent/ES345979A1/es

1967-10-12 Priority to BE705035D priority patent/BE705035A/xx

1967-10-12 Priority to AT926367A priority patent/AT275037B/de

1968-12-11 Publication of GB1136039A publication Critical patent/GB1136039A/en

Status Expired legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GB45695/66A 1966-10-12 1966-10-12 Improvements relating to immunosuppressive agents Expired GB1136039A (en)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
GB45695/66A GB1136039A (en)	1966-10-12	1966-10-12	Improvements relating to immunosuppressive agents
FR1552939D FR1552939A (xx)	1966-10-12	1967-10-11
FR124050A FR7058M (xx)	1966-10-12	1967-10-11
NL6713800A NL6713800A (xx)	1966-10-12	1967-10-11
ES345979A ES345979A1 (es)	1966-10-12	1967-10-11	Procedimiento para la preparacion de un agente proteinico anti-inmunitario.
BE705035D BE705035A (xx)	1966-10-12	1967-10-12
AT926367A AT275037B (de)	1966-10-12	1967-10-12	Verfahren zur Herstellung von Mitteln zur Hemmung von Immunitätsreaktionen

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB45695/66A GB1136039A (en)	1966-10-12	1966-10-12	Improvements relating to immunosuppressive agents

Publications (1)

Publication Number	Publication Date
GB1136039A true GB1136039A (en)	1968-12-11

Family

ID=10438194

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB45695/66A Expired GB1136039A (en)	1966-10-12	1966-10-12	Improvements relating to immunosuppressive agents

Country Status (6)

Country	Link
AT (1)	AT275037B (xx)
BE (1)	BE705035A (xx)
ES (1)	ES345979A1 (xx)
FR (2)	FR1552939A (xx)
GB (1)	GB1136039A (xx)
NL (1)	NL6713800A (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4043869A (en)	1972-07-13	1977-08-23	Koch-Light Laboratories, Ltd.	Water insoluble biologically active material
WO2015066550A1 (en) *	2013-10-31	2015-05-07	Resolve Therapeutics, Llc	Therapeutic nuclease-albumin fusions and methods

1966
- 1966-10-12 GB GB45695/66A patent/GB1136039A/en not_active Expired
1967
- 1967-10-11 FR FR1552939D patent/FR1552939A/fr not_active Expired
- 1967-10-11 NL NL6713800A patent/NL6713800A/xx unknown
- 1967-10-11 ES ES345979A patent/ES345979A1/es not_active Expired
- 1967-10-11 FR FR124050A patent/FR7058M/fr not_active Expired
- 1967-10-12 AT AT926367A patent/AT275037B/de active
- 1967-10-12 BE BE705035D patent/BE705035A/xx unknown

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4043869A (en)	1972-07-13	1977-08-23	Koch-Light Laboratories, Ltd.	Water insoluble biologically active material
WO2015066550A1 (en) *	2013-10-31	2015-05-07	Resolve Therapeutics, Llc	Therapeutic nuclease-albumin fusions and methods
US10988745B2 (en)	2013-10-31	2021-04-27	Resolve Therapeutics, Llc	Therapeutic nuclease-albumin fusions and methods
US12163165B2 (en)	2013-10-31	2024-12-10	Resolve Therapeutics, Llc	Nucleic acid molecules encoding nuclease-albumin fusion proteins

Also Published As

Publication number	Publication date
FR7058M (xx)	1969-06-23
BE705035A (xx)	1968-04-12
AT275037B (de)	1969-10-10
NL6713800A (xx)	1968-04-16
ES345979A1 (es)	1968-12-01
FR1552939A (xx)	1969-01-10

Similar Documents

Publication	Publication Date	Title
NL7714329A (nl)	1978-06-29	Werkwijze ter bereiding van 3-de-0-methylforti- micinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7507268A (nl)	1975-12-22	Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten.
GB1261230A (en)	1972-01-26	Acyl-substituted insulins
NL7706064A (nl)	1977-12-06	Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten.
GB1136039A (en)	1968-12-11	Improvements relating to immunosuppressive agents
NL7711414A (nl)	1978-04-25	Werkwijze ter bereiding van n-gesubstitueerde lactamen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7702180A (nl)	1977-09-05	Werkwijze ter bereiding van 9-gesubstitueerde- -8-azapurinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
GB1260963A (en)	1972-01-19	Substituted insulins
NL7409752A (nl)	1975-01-21	Werkwijze ter bereiding van 1,4-digesubstitueer- de piperidinen alsmede farmaceutische preparaten die deze verbindingen als actieve componenten omvatten.
GB1179787A (en)	1970-01-28	Stabilised and Potentiated Therapeutic Enzyme Compositions
IE34609L (en)	1971-01-17	Therapeutic substituted thiazolidinedione
GB1051686A (xx)
NL7511662A (nl)	1976-04-12	Werkwijze ter bereiding van 1-gesubstitueerde deri- vaten van 6'n-methyl-3'-4'-dideoxykanamycine b, alsmede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten.
NL7513011A (nl)	1976-05-10	Werkwijze ter bereiding van 1,2,3,4-tetrahydroiso- chinolinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7606457A (nl)	1976-12-21	Werkwijze ter bereiding van 7(beta)-acyloxycefalospo- rinen en 7(beta)-hydroxy-tussenprodukten alsmede farma- ceutische preparaten die de eerste verbindingen als actieve component omvatten.
GB1339737A (en)	1973-12-05	Diagnostic agents for primary hepatoma
ES2037603A1 (es)	1993-06-16	Procedimiento para la obtencion de preparados de enzimas, sin agentes superficie activos, pulverulentos o granulados conteniendo proteasa como enzima activa.
GB1327930A (en)	1973-08-22	1,4-benzodiazepine derivatives
NL7709466A (nl)	1978-03-02	Werkwijze ter bereiding van cefalosporinen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7708177A (nl)	1978-01-31	Werkwijze ter bereiding van cefemderivaten, als- mede farmaceutische preparaten die deze verbin- ding als actieve component bevatten.
GB1463908A (en)	1977-02-09	1-dimethylamino-methyl-6-substituted-4h-s-triazolo-4,3-a- 1,4-benzodiazepine
GB1117200A (en)	1968-06-19	A process for the manufacture of benzdiaz[1,4]epines
GB1197605A (en)	1970-07-08	Therapeutic Composition
NL7705446A (nl)	1977-11-21	Werkwijze ter bereiding van fenethanolaminen met farmaceutische werking alsmede preparaten die deze verbindingen als actieve component bevatten.
CA769021A (en)	1967-10-10	9.beta.,10.alpha.-STEROIDS, METHODS OF PRODUCING SAID COMPOUNDS AND METHODS OF PRODUCING PHARMACEUTIC PREPARATIONS CONTAINING SAID COMPOUNDS AS ACTIVE CONSTITUENTS AND SAID PREPARATIONS